Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 7/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 6/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.33 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.33 |
| ▸ | WHR1 | P49842 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | PI4KA | P42356 | 1/20 | 0.33 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.33 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.32 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16902216 | 0.99 | ADORA2A (0.36) | ADORA2AADORA1MEN1KMT2AATM | |
| SCHEMBL16902233 | 0.99 | ADORA2A (0.36) | ADORA2AADORA1MEN1KMT2AATM | |
| SCHEMBL18370742 | 0.98 | ADORA2A (0.36) | ADORA2AADORA1MEN1KMT2AATM | |
| SCHEMBL19106466 | 0.96 | ADORA2A (0.35) | ADORA2AADORA1MEN1KMT2AATM | |
| SCHEMBL26818992 | 0.95 | ADORA2A (0.36) | ADORA2AADORA1MEN1KMT2AATM | |
| SCHEMBL19106456 | 0.95 | MEN1 (0.35) | ADORA2AADORA1MEN1KMT2AATM | |
| SCHEMBL19106436 | 0.95 | ADORA2A (0.39) | ADORA2AADORA1MEN1KMT2AATM | |
| SCHEMBL26819540 | 0.95 | MEN1 (0.39) | ADORA2AADORA1MEN1KMT2AATM | |
| SCHEMBL19106395 | 0.95 | MEN1 (0.39) | ADORA2AADORA1MEN1KMT2AATM | |
| SCHEMBL18017990 | 0.95 | ADORA2A (0.39) | ADORA2AADORA1MEN1KMT2AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10734588-B2 | Compound for organic electronic element, and organic electronic element and electronic device using same | DUK SAN NEOLUX CO., LTD (KR) | 2020-08-04 | — | — | US | disclosed |
| US-20170200903-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | DUK SAN NEOLUX CO., LTD. (KR) | 2017-07-13 | — | — | US | disclosed |
| US-20170200903-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | DUK SAN NEOLUX CO., LTD. (KR) | 2017-07-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170200903-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | NFE2L2, ESR1, VDAC2 | ADORA2A 4441/4885ADORA1 4054/4885MEN1 1003/4885 |
| US-10734588-B2 | Compound for organic electronic element, and organic electronic element and electronic device using same | NFE2L2, ESR1, VDAC2 | ADORA2A 4441/4885ADORA1 4054/4885MEN1 1003/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.